MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kashiwagi, K.
Right arrow Articles by Williams, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kashiwagi, K.
Right arrow Articles by Williams, K.

0026-895X/97/040701-13$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:701-713 (1997).

Block and Modulation of N-Methyl-D-Aspartate Receptors by Polyamines and Protons: Role of Amino Acid Residues in the Transmembrane and Pore-Forming Regions of NR1 and NR2 Subunits

Keiko Kashiwagi, Albert J. Pahk, Takashi Masuko, Kazuei Igarashi, and Keith Williams

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania (A.J.P., K.W.), and Faculty of Pharmaceutical Sciences, Chiba University, Inage-Ku, Chiba 263, Japan (K.K., T.M., K.I.)

N-Methyl-D-aspartate (NMDA) receptors are modulated by extracellular spermine and protons and are blocked in a voltage-dependent manner by spermine and polyamine derivatives such as N1-dansyl-spermine (N1-DnsSpm). The effects of mutations in the first and third transmembrane domains (M1 and M3) and the pore-forming loop (M2) of NMDA receptor subunits were studied. Surprisingly, some mutations in M2 and M3 of the NR1 subunit, including mutations at W608 and N616 in M2, reduced spermine stimulation and proton inhibition. These mutations may have long-range allosteric effects or may change spermine- and pH-dependent gating processes rather than directly affecting the binding sites for these modulators because spermine stimulation and proton inhibition are not voltage dependent and are thought to involve binding sites outside the pore-forming regions of the receptor. A number of mutations in M1-M3, including mutations at tryptophan and tyrosine residues near the extracellular sides of M1 and M3, reduced block by spermine and N1-DnsSpm. The effects of these mutants on channel block were characterized in detail by using N1-DnsSpm, which produces block but not stimulation of NMDA receptors. Block by N1-DnsSpm was studied by using voltage ramps analyzed with the Woodhull model of channel block. Mutations at W563 (in M1) and E621 (immediately after M2) in the NR1A subunit and at Y646 (in M3) and N616 (in the M2 loop) in the NR2B subunit reduced the affinity for N1-DnsSpm without affecting the voltage dependence of block. These residues may form part of a binding site for N1-DnsSpm. Mutation of a tryptophan residue at position W607 in the M2 region of NR2B greatly reduced block by N1-DnsSpm, and N1-DnsSpm could easily permeate channels containing this mutation. The results suggest that at least parts of the M1 and M3 segments contribute to the pore or vestibule of the NMDA channel and that a tryptophan in M2 (W607 in NR2B) may contribute to the narrow constriction of the pore.

Copyright © by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
L. Jin, M. Miyazaki, S. Mizuno, M. Takigawa, T. Hirose, K. Nishimura, T. Toida, K. Williams, K. Kashiwagi, and K. Igarashi
The Pore Region of N-Methyl-D-aspartate Receptors Differentially Influences Stimulation and Block by Spermine
J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 68 - 77.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
S. M. Dravid, K. Erreger, H. Yuan, K. Nicholson, P. Le, P. Lyuboslavsky, A. Almonte, E. Murray, C. Mosley, J. Barber, et al.
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block
J. Physiol., May 15, 2007; 581(1): 107 - 128.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
F.-S. Lo and R. S. Erzurumlu
Conversion of Functional Synapses into Silent Synapses in the Trigeminal Brainstem after Neonatal Peripheral Nerve Transection
J. Neurosci., May 2, 2007; 27(18): 4929 - 4934.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. Jin, H. Sugiyama, M. Takigawa, D. Katagiri, H. Tomitori, K. Nishimura, N. Kaur, O. Phanstiel IV, M. Kitajima, H. Takayama, et al.
Comparative Studies of Anthraquinone- and Anthracene-Tetraamines as Blockers of N-Methyl-D-aspartate Receptors
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 47 - 55.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Awobuluyi, J. Yang, Y. Ye, J. E. Chatterton, A. Godzik, S. A. Lipton, and D. Zhang
Subunit-Specific Roles of Glycine-Binding Domains in Activation of NR1/NR3 N-Methyl-D-aspartate Receptors
Mol. Pharmacol., January 1, 2007; 71(1): 112 - 122.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. Hu and F. Zheng
Molecular Determinants of Glycine-Independent Desensitization of NR1/NR2A Receptors
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 563 - 569.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. Kashiwagi, I. Tanaka, M. Tamura, H. Sugiyama, T. Okawara, M. Otsuka, T. N. Sabado, K. Williams, and K. Igarashi
Anthraquinone Polyamines: Novel Channel Blockers to Study N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 884 - 893.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
N. Chen, B. Li, T. H. Murphy, and L. A. Raymond
Site within N-Methyl-D-aspartate Receptor Pore Modulates Channel Gating
Mol. Pharmacol., January 1, 2004; 65(1): 157 - 164.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C.-M. Low, P. Lyuboslavsky, A. French, P. Le, K. Wyatte, W. H. Thiel, E. M. Marchan, K. Igarashi, K. Kashiwagi, K. Gernert, et al.
Molecular Determinants of Proton-Sensitive N-Methyl-D-aspartate Receptor Gating
Mol. Pharmacol., June 1, 2003; 63(6): 1212 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
F. A. Middleton, K. Mirnics, J. N. Pierri, D. A. Lewis, and P. Levitt
Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia
J. Neurosci., April 1, 2002; 22(7): 2718 - 2729.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
F. N. Single, A. Rozov, N. Burnashev, F. Zimmermann, D. F. Hanley, D. Forrest, T. Curran, V. Jensen, O. Hvalby, R. Sprengel, et al.
Dysfunctions in Mice by NMDA Receptor Point Mutations NR1(N598Q) and NR1(N598R)
J. Neurosci., April 1, 2000; 20(7): 2558 - 2566.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. Yamakura, K. Sakimura, and K. Shimoji
N-Methyl-D-Aspartate Receptor Channel Block by Meperidine Is Dependent on Extracellular pH
Anesth. Analg., April 1, 2000; 90(4): 928 - 932.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. Masuko, T. Kuno, K. Kashiwagi, T. Kusama, K. Williams, and K. Igarashi
Stimulatory and Inhibitory Properties of Aminoglycoside Antibiotics at N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1026 - 1033.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
T. Masuko, K. Kashiwagi, T. Kuno, N. D. Nguyen, A. J. Pahk, J.-i. Fukuchi, K. Igarashi, and K. Williams
A Regulatory Domain (R1-R2) in the Amino Terminus of the N-Methyl-D-Aspartate Receptor: Effects of Spermine, Protons, and Ifenprodil, and Structural Similarity to Bacterial Leucine/Isoleucine/Valine Binding Protein
Mol. Pharmacol., June 1, 1999; 55(6): 957 - 969.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis
The Glutamate Receptor Ion Channels
Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
W. Danysz and C. G. Parsons
Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications
Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. F. Traynelis, M. F. Burgess, F. Zheng, P. Lyuboslavsky, and J. L. Powers
Control of Voltage-Independent Zinc Inhibition of NMDA Receptors by the NR1 Subunit
J. Neurosci., August 15, 1998; 18(16): 6163 - 6175.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. Williams, A. J. Pahk, K. Kashiwagi, T. Masuko, N. D. Nguyen, and K. Igarashi
The Selectivity Filter of the N-Methyl-D-Aspartate Receptor: A Tryptophan Residue Controls Block and Permeation of Mg2+
Mol. Pharmacol., May 1, 1998; 53(5): 933 - 941.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. Igarashi, A. Shirahata, A. J. Pahk, K. Kashiwagi, and K. Williams
Benzyl-polyamines: Novel, Potent N-Methyl-D-aspartate Receptor Antagonists
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 533 - 540.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics